ResMed Inc. (RMD) Earnings History
Annual and quarterly earnings data from 1993 to 2025
Loading earnings history...
RMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 59.4% | 32.7% | 27.2% |
| 2024 | 56.7% | 28.2% | 21.8% |
| 2023 | 55.8% | 26.8% | 21.3% |
| 2022 | 56.6% | 28.0% | 21.8% |
| 2021 | 57.5% | 28.3% | 14.8% |
Download Data
Export RMD earnings history in CSV or JSON format
Free sign-in required to download data
ResMed Inc. (RMD) Earnings Overview
As of May 8, 2026, ResMed Inc. (RMD) reported trailing twelve-month net income of $1.52B, reflecting +37.4% year-over-year growth. The company earned $10.33 per diluted share over the past four quarters, with a net profit margin of 27.2%.
Looking at the long-term picture, RMD's 5-year EPS compound annual growth rate (CAGR) stands at +17.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $1.40B in fiscal 2025, representing a new all-time high.
ResMed Inc. maintains industry-leading profitability with a gross margin of 59.4%, operating margin of 32.7%, and net margin of 27.2%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including PHG ($895M net income, 5.0% margin), ITGR ($142M net income, 5.6% margin), NVCR (-$173M net income, -20.8% margin), RMD has outperformed on profitability metrics. Compare RMD vs PHG →
RMD Earnings vs Peers
Earnings metrics vs comparable public companies
RMD Historical Earnings Data (1993–2025)
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.40B | +37.2% | $1.69B | $9.51 | 27.2% | 32.7% |
| 2024 | $1.02B | +13.7% | $1.32B | $6.92 | 21.8% | 28.2% |
| 2023 | $898M | +15.2% | $1.13B | $6.09 | 21.3% | 26.8% |
| 2022 | $779M | +64.3% | $1.00B | $5.30 | 21.8% | 28.0% |
| 2021 | $475M | -23.7% | $904M | $3.24 | 14.8% | 28.3% |
| 2020 | $622M | +53.7% | $810M | $4.27 | 21.0% | 27.4% |
| 2019 | $405M | +28.2% | $579M | $2.80 | 15.5% | 22.2% |
| 2018 | $316M | -7.8% | $542M | $2.19 | 13.5% | 23.2% |
| 2017 | $342M | -2.9% | $426M | $2.40 | 16.6% | 20.6% |
| 2016 | $352M | -0.1% | $429M | $2.49 | 19.2% | 23.3% |
Full RMD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRMD — Frequently Asked Questions
Quick answers to the most common questions about buying RMD stock.
Is RMD growing earnings?
RMD EPS is $10.33, with earnings growth accelerating to +37.4%. This exceeds the 5-year CAGR of +17.4%. TTM net income reached $1.5B.
What are RMD's profit margins?
ResMed Inc. net margin is +27.2%, with operating margin at +32.7%. Above-average margins indicate pricing power.
How consistent are RMD's earnings?
RMD earnings data spans 1993-2025. The accelerating earnings trend is +37.4% YoY. Historical data enables comparison across business cycles.